Provided by Tiger Trade Technology Pte. Ltd.

Biogen

189.18
+5.242.85%
Post-market: 189.180.00000.00%17:54 EDT
Volume:775.19K
Turnover:145.77M
Market Cap:27.75B
PE:21.52
High:189.38
Open:184.91
Low:184.91
Close:183.94
52wk High:202.41
52wk Low:110.04
Shares:146.70M
Float Shares:146.23M
Volume Ratio:0.71
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.79
EPS(LYR):8.79
ROE:7.39%
ROA:6.14%
PB:1.52
PE(LYR):21.52

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX) and Biogen (BIIB)

TIPRANKS
·
Jan 22

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 22

Wells Fargo Reaffirms Their Hold Rating on Biogen (BIIB)

TIPRANKS
·
Jan 21

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 21

RBC Trims Price Target on Biogen to $217 From $220, Keeps Outperform Rating

MT Newswires Live
·
Jan 20

Biogen (BIIB) Valuation Check As High Dose Spinraza Wins Key European Approval

Simply Wall St.
·
Jan 17

Goldman Sachs: Leqembi and Pipeline Drive Structural Revenue and Profit Growth, Initiates Biogen (BIIB.US) with "Buy" Rating

Stock News
·
Jan 15

BGI Genomics, Roche roll out diagnostic tests for Alzheimer's in China

Reuters
·
Jan 15

BUZZ-Biogen falls after flagging $222 million charge to profit in Q4

Reuters
·
Jan 15

Biogen Shares Fall 6% After Co Expects $222 Mln Expense for Q4, Impacting Earnings by $1.26 per Share

THOMSON REUTERS
·
Jan 14

Biogen Down Over 6%, on Pace for Largest Percent Decrease Since July 2024 -- Data Talk

Dow Jones
·
Jan 14

Jefferies Keeps Their Buy Rating on Biogen (BIIB)

TIPRANKS
·
Jan 14

Biogen Bets on At-Home Alzheimer's Drug, Calling It the "Winning Chip" Against Eli Lilly

Stock News
·
Jan 14

Biogen to Take $222M Charge in 4Q Results

Dow Jones
·
Jan 14

BRIEF-Biogen - Charge To Impact Q4 Net Income By $1.26 Per Share - SEC Filing

Reuters
·
Jan 14

Biogen sees Q4 pre-tax charge of $222M, or $1.26 per share

TIPRANKS
·
Jan 14

Biogen - Expects $222 Mln Expense for Q4 2025 - SEC Filing

THOMSON REUTERS
·
Jan 14

Biogen - Charge to Impact Q4 Net Income by $1.26 per Share - SEC Filing

THOMSON REUTERS
·
Jan 14

Biogen Inc. Stock Slides 3.9%, Underperforms Peers

Dow Jones
·
Jan 14

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 13